<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR40" class="ref">
 <span class="label" xmlns="http://www.w3.org/1999/xhtml">40.</span>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Fessas</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">P</span>
   </name>
   <span class="etal" xmlns="http://www.w3.org/1999/xhtml"/>
  </person-group>
  <div class="article-title" xmlns="http://www.w3.org/1999/xhtml">A molecular and preclinical comparison of the PD-1-targeted T-cell checkpoint inhibitors nivolumab and pembrolizumab</div>
  <div class="source" xmlns="http://www.w3.org/1999/xhtml">Semin. Oncol.</div>
  <span class="year" xmlns="http://www.w3.org/1999/xhtml">2017</span>
  <span class="volume" xmlns="http://www.w3.org/1999/xhtml">44</span>
  <span class="fpage" xmlns="http://www.w3.org/1999/xhtml">136</span>
  <span class="lpage" xmlns="http://www.w3.org/1999/xhtml">140</span>
  <span pub-id-type="doi" class="pub-id" xmlns="http://www.w3.org/1999/xhtml">10.1053/j.seminoncol.2017.06.002</span>
  <?supplied-pmid 28923212?>
  <span pub-id-type="pmid" class="pub-id" xmlns="http://www.w3.org/1999/xhtml">28923212</span>
 </element-citation>
</ref>
